Granules India Ltd

Granules India has experienced fluctuating net sales and profits, peaking at 4,511.92 Cr in March 2023 before a slight decline by March 2025, while operating profit increased to 958.16 Cr due to reduced raw material costs. The company showed resilience with growth in total assets and improved cash flow from operating activities, despite variations in profit before and after tax.

On 24-Nov, Granules India Ltd witnessed a notable decline in its share price, falling by 2.21% to close at ₹531.45. This drop reflects a continuation of recent downward momentum amid subdued investor participation and underperformance relative to broader market benchmarks.

Granules India has experienced a slight decline in net sales, reaching 4,481.61 Cr in March 2025, while operating profit increased to 958.16 Cr due to reduced raw material costs. Despite a minor drop in profit after tax to 501.52 Cr, the company showed strong cash flow from operations at 866.00 Cr and improved earnings per share to 20.68.

As of 18-Nov, Granules India Ltd is priced at 561.00, down 0.08%, with a decline in investor participation despite outperforming its sector. The stock has shown mixed performance with a recent increase over the week but a decline over the month and year-to-date, raising concerns about long-term growth potential.

As of 17 November 2025, Granules India exhibits a mildly bullish trend, supported by bullish daily moving averages and a weekly MACD, despite mixed signals from monthly indicators.

As of November 14, 2025, the trend is bullish with moderate strength, supported by a bullish MACD, moving averages, and On-Balance Volume, though caution is advised due to mildly bearish monthly MACD and KST indicators.

As of November 14, 2025, Granules India shows a bullish trend with moderate strength, supported by positive indicators like MACD and moving averages, but caution is advised due to mixed signals from longer-term indicators.

As of November 14, 2025, the trend has shifted to bullish with moderate strength, supported by bullish indicators like the MACD and moving averages, though caution is advised due to mildly bearish monthly MACD and KST signals.

Granules India has experienced fluctuating performance, with net sales at 4,481.61 Cr in March 2025, a slight decline from the previous year, but notable growth in operating profit (PBDIT) to 958.16 Cr and profit after tax to 501.52 Cr. Total assets and liabilities increased to 6,184.73 Cr, while cash flow from operating activities improved significantly to 866.00 Cr, indicating enhanced operational efficiency.

Granules India has shown mixed historical performance, with net sales slightly declining to 4,481.61 Cr in March 2025 from previous years, while operating profit increased to 958.16 Cr. Despite a decrease in profit after tax to 501.52 Cr, the company improved cash flow significantly to 866.00 Cr.

As of 11-Nov, Granules India Ltd's stock price is Rs 535.95, down 2.58%, with a total decline of 3.41% over the last two days. Despite strong fundamentals, the stock is underperforming compared to its sector and the broader market, indicating negative market sentiment.

As of November 6, 2025, Granules India shows a mildly bullish trend, supported by daily moving averages and weekly indicators, but mixed signals from monthly indicators suggest a cautious approach.

As of November 6, 2025, Granules India is fairly valued with a PE ratio of 28.14, an EV to EBITDA of 15.28, and a ROCE of 15.74%, making it more attractive compared to peers like Sun Pharma and Divi's Lab, despite a recent stock return of -4.20% against the Sensex, while showing a significant long-term gain of 290.73% over the past decade.